Literature DB >> 21437933

Repetitive hypoxia extends endogenous neurovascular protection for stroke.

Ann M Stowe1, Tamer Altay, Angela B Freie, Jeffrey M Gidday.   

Abstract

OBJECTIVE: Brief systemic hypoxia protects the rodent brain from subsequent ischemic injury, although the protection wanes within days. We hypothesized that the duration of ischemic tolerance could be extended from days to months by repeated intermittent hypoxia of varying magnitude and duration.
METHODS: Infarction volumes following a 60-minute transient middle cerebral artery occlusion were determined in adult male mice 2 days through 8 weeks after completion of a 2-week repetitive hypoxic preconditioning (RHP) protocol. Separate cohorts were studied for the protective effects of RHP on postischemic and cytokine-induced cerebrovascular inflammation, and for potential deleterious effects of the RHP stimulus itself.
RESULTS: RHP protection against transient focal stroke persisted for 8 weeks. Leukocyte adherence to cortical venules was attenuated in response to stroke, as well as following tumor necrosis factor-α administration, indicating that reductions in postischemic inflammation were not secondary to smaller infarct volumes. RHP reduced poststroke leukocyte diapedesis concomitant with a long-lasting downregulation of endothelial adhesion molecule mRNAs, and also reduced postischemic blood--brain barrier permeability to endogenous immunoglobulin G. RHP was without effect on hippocampal CA1 pyramidal cell viability, only transiently elevated hematocrit, and did not affect the magnitude of cerebral blood flow during and after ischemia.
INTERPRETATION: Taken together, our findings reveal a novel form of epigenetic neurovascular plasticity characterized by a prominent anti-inflammatory phenotype that provides protection against stroke many weeks longer than previously established windows of preconditioning-induced tolerance. Translating these endogenous protective mechanisms into therapeutics could afford sustained periods of cerebroprotection in subpopulations of individuals at identified risk for stroke.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21437933      PMCID: PMC3117913          DOI: 10.1002/ana.22367

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  54 in total

Review 1.  Structural plasticity and memory.

Authors:  Raphael Lamprecht; Joseph LeDoux
Journal:  Nat Rev Neurosci       Date:  2004-01       Impact factor: 34.870

2.  Prevention of inflammation is a mechanism of preconditioning-induced neuroprotection against focal cerebral ischemia.

Authors:  Kellie K Bowen; Michelle Naylor; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2006-06-06       Impact factor: 3.921

3.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

Authors:  Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

4.  Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats.

Authors:  Xin-Hong Zhu; Hua-Cheng Yan; Jie Zhang; Hong-Da Qu; Xing-Sheng Qiu; Liang Chen; Shu-Ji Li; Xiong Cao; Jonathan C Bean; Long-Hua Chen; Xi-He Qin; Ji-Hong Liu; Xiao-Chun Bai; Lin Mei; Tian-Ming Gao
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

5.  Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression.

Authors:  F C Barone; R F White; P A Spera; J Ellison; R W Currie; X Wang; G Z Feuerstein
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

6.  Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Authors:  Yanli Zhu; Lihong Zhang; Jeffrey M Gidday
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

7.  Neutrophil elastase and neurovascular injury following focal stroke and reperfusion.

Authors:  Ann M Stowe; Tracy L Adair-Kirk; Ernesto R Gonzales; Ronald S Perez; Aarti R Shah; Tae S Park; Jeffrey M Gidday
Journal:  Neurobiol Dis       Date:  2009-04-22       Impact factor: 5.996

8.  Time course of cardiovascular and hematological responses in rats exposed to chronic intermittent hypobaric hypoxia (4600 m).

Authors:  Patricia Siqués; Julio Brito; Fabiola León-Velarde; Luis Barrios; Juan José De La Cruz; Vasthi López; Rafael Herruzo
Journal:  High Alt Med Biol       Date:  2006       Impact factor: 1.981

Review 9.  Regulation of oxygen homeostasis by hypoxia-inducible factor 1.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2009-04

10.  Multi-modal characterisation of the neocortical clip model of focal cerebral ischaemia by MRI, behaviour and immunohistochemistry.

Authors:  Maria Ashioti; John S Beech; Andrew S Lowe; Mayke B Hesselink; Michael Modo; Steve C R Williams
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

View more
  54 in total

1.  The hypoxic preconditioning agent deferoxamine induces poly(ADP-ribose) polymerase-1-dependent inhibition of the mitochondrial respiratory chain.

Authors:  Ana Cañuelo; Rubén Martínez-Romero; Esther Martínez-Lara; José A Sánchez-Alcázar; Eva Siles
Journal:  Mol Cell Biochem       Date:  2011-12-07       Impact factor: 3.396

2.  Resveratrol Preconditioning Induces a Novel Extended Window of Ischemic Tolerance in the Mouse Brain.

Authors:  Kevin B Koronowski; Kunjan R Dave; Isabel Saul; Vladimir Camarena; John W Thompson; Jake T Neumann; Juan I Young; Miguel A Perez-Pinzon
Journal:  Stroke       Date:  2015-07-09       Impact factor: 7.914

3.  Quantification of neurovascular protection following repetitive hypoxic preconditioning and transient middle cerebral artery occlusion in mice.

Authors:  Katherine Poinsatte; Uma Maheswari Selvaraj; Sterling B Ortega; Erik J Plautz; Xiangmei Kong; Jeffrey M Gidday; Ann M Stowe
Journal:  J Vis Exp       Date:  2015-05-04       Impact factor: 1.355

4.  Physiological cerebrovascular remodeling in response to chronic mild hypoxia: A role for activated protein C.

Authors:  Laurent Burnier; Amin Boroujerdi; Jose A Fernández; Jennifer V Welser-Alves; John H Griffin; Richard Milner
Journal:  Exp Neurol       Date:  2016-07-10       Impact factor: 5.330

5.  A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord.

Authors:  Sebok K Halder; Richard Milner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-26       Impact factor: 11.205

6.  Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.

Authors:  Amin Boroujerdi; Jennifer V Welser-Alves; Richard Milner
Journal:  Exp Neurol       Date:  2013-09-20       Impact factor: 5.330

Review 7.  The epigenetics of stroke recovery and rehabilitation: from polycomb to histone deacetylases.

Authors:  Jessica Elder; Mar Cortes; Avrielle Rykman; Justin Hill; Saravanan Karuppagounder; Dylan Edwards; Rajiv R Ratan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 8.  Cardiorespiratory coupling in health and disease.

Authors:  Alfredo J Garcia; Jenna E Koschnitzky; Tatiana Dashevskiy; Jan-Marino Ramirez
Journal:  Auton Neurosci       Date:  2013-03-13       Impact factor: 3.145

9.  Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Authors:  Eugenia B Manukhina; H Fred Downey; Xiangrong Shi; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

10.  Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway.

Authors:  Bradley K Wacker; Jennifer L Perfater; Jeffrey M Gidday
Journal:  J Neurochem       Date:  2012-11-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.